Note that individuals assigned male sex at birth who were treated with estrogens (and androgen depletion) as gender-affirming therapy developed insulin resistance (111), suggesting that in males, E2 improves insulin sensitivity in the presence of intact AR action. The gene discussed is INS; the disease is Insulin resistance.